Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors

Table 4

Pancreatic cancer serum biomarkers identified after MS-based studies.

Putative pancreatic cancer biomarker	Expression in pancreatic ca sera	References
Apolipoprotein CIII	Increased	[82]
Serum amyloid protein A	Increased	[83]
Apolipoprotein A-II	Decreased	[84]
Apolipoprotein A-I	Decreased	[84]
Transthyretin	Decreased	[84]
Alpha-2 macroglobulin	Increased	[85]
Ceruloplasmin	Increased	[85]
Complement 3C	Increased	[85]
Platelet factor 4	Decreased	[86]
Mannose-binding lectin 2	Increased	[87]
Myosin light chain kinase 2	Increased	[87]
CXC chemokine ligand 7	Decreased	[88]
TIMP1-ICAM1	Increased	[89]
Alpha-1 antitrypsin	Increased	[90]
Fibrinogen gamma	Increased	[91]
C14orf166	Increased	[92]
Alpha-1 antichymotrypsin	Increased	[93]